Moderna & Germany

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Germany: Germany is receiving and treating a US citizen infected with Ebola and quarantining exposed individuals, playing a role in the international medical response.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.

Germany: Germany, along with other European governments, has also cut development aid, contributing to the overall reduction in global health funding.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

Germany: An American citizen infected with Ebola in the Democratic Republic of the Congo>>> is receiving care in Germany>>>, demonstrating international medical support for severe cases.